What is the level of liabilities of KP Tissue this year?
KP Tissue has a debt balance of 2.25 M CAD this year.
In 2024, KP Tissue's total liabilities amounted to 2.25 M CAD, a -70.7% difference from the 7.68 M CAD total liabilities in the previous year.
KP Tissue's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating KP Tissue's financial stability, operational efficiency, and long-term viability.
By comparing KP Tissue's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
KP Tissue's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in KP Tissue’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
KP Tissue has a debt balance of 2.25 M CAD this year.
The liabilities of KP Tissue have increased by -70.7% dropped compared to the previous year.
High liabilities can pose a risk for investors of KP Tissue, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that KP Tissue has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of KP Tissue can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of KP Tissue can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of KP Tissue include investments, acquisitions, operating costs, and sales development.
The liabilities of KP Tissue are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, KP Tissue can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, KP Tissue paid a dividend of 0.72 CAD . This corresponds to a dividend yield of about 8.62 %. For the coming 12 months, KP Tissue is expected to pay a dividend of 1.19 CAD.
The current dividend yield of KP Tissue is 8.62 %.
KP Tissue pays a quarterly dividend. This is distributed in the months of July, October, October, January.
KP Tissue paid dividends every year for the past 14 years.
For the upcoming 12 months, dividends amounting to 1.19 CAD are expected. This corresponds to a dividend yield of 14.25 %.
KP Tissue is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of KP Tissue from 1/15/2025 amounting to 0.18 CAD, you needed to have the stock in your portfolio before the ex-date on 12/31/2024.
The last dividend was paid out on 1/15/2025.
In the year 2023, KP Tissue distributed 0.72 CAD as dividends.
The dividends of KP Tissue are distributed in CAD.
Our stock analysis for KP Tissue Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KP Tissue Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.